{{Rsnum
|rsid=7536700
|Gene=ILF2
|Chromosome=1
|position=153668351
|Orientation=plus
|GMAF=0.1244
|Gene_s=ILF2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 82.3 | 16.8 | 0.9
| HCB | 97.8 | 2.2 | 0.0
| JPT | 98.2 | 1.8 | 0.0
| YRI | 48.3 | 41.5 | 10.2
| ASW | 36.8 | 47.4 | 15.8
| CHB | 97.8 | 2.2 | 0.0
| CHD | 96.3 | 3.7 | 0.0
| GIH | 68.3 | 28.7 | 3.0
| LWK | 40.4 | 45.9 | 13.8
| MEX | 81.0 | 17.2 | 1.7
| MKK | 35.1 | 40.9 | 24.0
| TSI | 81.4 | 18.6 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23502783
  |Trait=Multiple myeloma (IgH translocation)
  |Title=The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.
  |RiskAllele=A
  |Pval=9E-6
  |OR=1.86
  |ORtxt=[1.42-2.46]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}